CRISPR Therapeutics AG (CRSP) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for CRISPR Therapeutics AG (CRSP) over the last 11 years, with Q3 2025 value amounting to $93.9 million.
- CRISPR Therapeutics AG's Shares Outstanding rose 1000.4% to $93.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.9 million, marking a year-over-year increase of 1000.4%. This contributed to the annual value of $85.7 million for FY2024, which is 711.81% up from last year.
- CRISPR Therapeutics AG's Shares Outstanding amounted to $93.9 million in Q3 2025, which was up 1000.4% from $88.4 million recorded in Q2 2025.
- In the past 5 years, CRISPR Therapeutics AG's Shares Outstanding registered a high of $93.9 million during Q3 2025, and its lowest value of $75.7 million during Q1 2021.
- Moreover, its 5-year median value for Shares Outstanding was $79.4 million (2023), whereas its average is $81.3 million.
- As far as peak fluctuations go, CRISPR Therapeutics AG's Shares Outstanding surged by 2437.28% in 2021, and later surged by 150.66% in 2023.
- Quarter analysis of 5 years shows CRISPR Therapeutics AG's Shares Outstanding stood at $77.0 million in 2021, then rose by 1.98% to $78.5 million in 2022, then rose by 1.95% to $80.0 million in 2023, then increased by 7.12% to $85.7 million in 2024, then rose by 9.48% to $93.9 million in 2025.
- Its last three reported values are $93.9 million in Q3 2025, $88.4 million for Q2 2025, and $86.4 million during Q1 2025.